Vivo Capital, LLC Verona Pharma PLC Transaction History
Vivo Capital, LLC
- $683 Million
- Q3 2024
A detailed history of Vivo Capital, LLC transactions in Verona Pharma PLC stock. As of the latest transaction made, Vivo Capital, LLC holds 3,549,758 shares of VRNA stock, worth $152 Million. This represents 14.95% of its overall portfolio holdings.
Number of Shares
3,549,758
Previous 3,549,758
-0.0%
Holding current value
$152 Million
Previous $51.3 Million
98.96%
% of portfolio
14.95%
Previous 7.58%
Shares
8 transactions
Others Institutions Holding VRNA
# of Institutions
167Shares Held
68.7MCall Options Held
704KPut Options Held
685K-
Perceptive Advisors LLC New York, NY6.32MShares$270 Million4.75% of portfolio
-
Nea Management Company, LLC Timonium, MD5.58MShares$238 Million12.27% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.01MShares$214 Million2.01% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx4.22MShares$180 Million2.52% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.38MShares$144 Million5.24% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $2.6B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...